Incannex Healthcare Inc. Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes
Incannex Healthcare Inc. (IXHL) reported Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes of -$4.14 million for the 12-month period ending 2023-06-30, per its 20-F filed 2023-10-31.
Discontinued › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges · last filed 2023-10-31
| Period end | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month |
|---|---|
| 2023-06-30 | -$4.14M 20-F · filed 2023-10-31 |
| 2022-06-30 | $28.38M 20-F · filed 2023-10-31 |
| 2021-06-30 | $5.52M 20-F · filed 2023-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B |